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Abstract 
Background: Enantiopure 2‑hydroxy acids are key intermediates for the synthesis of pharmaceuticals and fine 
chemicals. We present an enantioselective cascade biocatalysis using recombinant microbial cells for deracemization 
of racemic 2‑hydroxy acids that allows for efficient production of enantiopure 2‑hydroxy acids.
Results: The method was realized by a single recombinant Escherichia coli strain coexpressing three enzymes: (S)‑
2‑hydroxy acid dehydrogenase, (R)‑2‑keto acid reductase and glucose dehydrogenase. One enantiomer [(S)‑2‑hydroxy 
acid] is firstly oxidized to the keto acid with (S)‑2‑hydroxy acid dehydrogenase, while the other enantiomer [(R)‑2‑hy‑
droxy acid] remains unchanged. Then, the keto acid obtained reduced to the opposite enantiomer with (R)‑2‑keto 
acid reductase plus cofactor regeneration enzyme glucose dehydrogenase subsequently. The recombinant E. coli 
strain coexpressing the three enzymes was proven to be a promising biocatalyst for the cascade bioconversion of a 
structurally diverse range of racemic 2‑hydroxy acids, giving the corresponding (R)‑2‑hydroxy acids in up to 98.5 % 
conversion and >99 % enantiomeric excess.
Conclusions: In summary, a cascade biocatalysis was successfully developed to prepare valuable (R)‑2‑hydroxy acids 
with an efficient three‑enzyme system. The developed elegant cascade biocatalysis possesses high atom efficiency 
and represents a promising strategy for production of highly valued (R)‑2‑hydroxy acids.
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Background
Enantiopure 2-hydroxy acids are among the most impor-
tant building blocks for synthesizing pharmaceuticals 
and fine chemicals [1]. For example, (R)-(-)-mandelic 
acid is widely used as an intermediate for the prepara-
tion of antibiotics, antiobesity drugs, and antitumor 
agents [2]. (R)-o-Chloromandelic acid is the most pre-
ferred chiral building block for the industrial synthesis 
of anti-thrombotic agent, a best-selling cardiovascular 
drug [3]. (R)-2-Hydroxy-4-phenylbutyric acid is an inter-
mediate in the manufacture of angiotensin converting 
enzyme inhibitors [4]. (R)-3-Phenyllactic acid is used as 
a precursor for the synthesis of englitazone which has 
excellent hypoglycemic effect [5]. Due to their impor-
tance, many enantioselective routes for their synthe-
sis have been developed and a great progress has been 
achieved in recent years. Traditionally, their industrial 
production mainly relies on the chemical approaches 
such as chemical kinetic resolution with chiral agent. 
However, it does not always satisfactorily work because 
of expensive agent, unsatisfied enantiomeric excess (ee) 
of product or low yield (e.g., <50 %).
Biocatalysis is increasingly being used to develop effi-
cient and green processes for chiral 2-hydroxy acids 
synthesis [6]. Several enzymatic approaches have been 
reported for synthesizing chiral 2-hydroxy acids in the lit-
erature [1, 7, 8], including reduction of 2-keto acids with 
stereoselective 2-keto acid reductase [9], enantioselective 
oxidation of racemic 2-hydroxy acids with 2-hydroxy acid 
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dehydrogenase [10] or diols with alditol oxidase [11], reso-
lution of 2-hydroxy acids with lipase [12] or esterase [1], 
hydrolysis of 2-hydroxynitriles with nitrilase [13, 14], enan-
tioselective addition of HCN to aldehydes with oxynitrilase 
followed by nitrilase hydrolysis [15], hydrolysis of amide 
with amidase [16], oxidation of L-amino acids with an 
L-amino acid deaminase followed by asymmetric reduc-
tion of the keto acid with an 2-hydroxyisocaproate dehy-
drogenase [17], and deracemization of racemic 2-hydroxy 
acids by cascade biocatalysis [18] (Scheme 1). Among all 
these approaches, deracemization of racemate by cascade 
biocatalysis is one of the most attractive methods because 
it allows to completely transform a cheap racemate into a 
single stereoisomeric product without byproduct. Further-
more, this enantioselective cascade biocatalysis enables 
multistep reactions to be performed in one pot, which cir-
cumvented yield-reducing and time-consuming isolation 
of intermediates [19]. Recently, several types of enantiose-
lective cascade biocatalysis have been developed for chiral 
synthesis [20–25], such as the deracemization of sec-alco-
hols, amines and amino acids [26–30], amination of alco-
hols to chiral amines [31], preparation of chiral α-hydroxy 
ketones from epoxides [32], and biotransformation of 
α-hydroxy acids into chiral α-amino acids [33, 34].
In this work, we aim to develop an enantioselec-
tive cascade biocatalysis for deracemization of racemic 
2-hydroxy acids to (R)-2-hydroxy acids via an oxida-
tion–reduction sequence using a recombinant Escheri-
chia coli expressing three enzymes (Scheme  2). One 
enantiomer [(S)-2-hydroxy acid] is firstly oxidized to 
the keto acid with enantioselective (S)-2-hydroxy acid 
dehydrogenase [(S)-2-HADH] while the other enanti-
omer [(R)-2-hydroxy acid] remains unchanged. The keto 
acid obtained is then bioreduced to the opposite enan-
tiomer with stereoselective (R)-2-keto acid reductase 
[(R)-2-KAR] plus cofactor regeneration enzyme glucose 
dehydrogenase (GDH) subsequently. The recombinant 
E. coli strain coexpressing (S)-2-HADH, (R)-2-KAR and 
GDH was proven to be a promising biocatalyst. A wide 
range of 2-hydroxy acids can be deracemized to (R)-
2-hydroxy acids with near-perfect stereo purity and high 
conversion. This method by cascade enantioselective oxi-
dation and asymmetric reduction with a single recombi-
nant strain represents a cheap, easy and environmental 
approach for synthesizing (R)-2-hydroxy acids from their 
racemates.
Results and discussion
Construction of recombinant E. coli strain expressing 
(S)‑2‑HADH
We recently established a high-throughput screening 





























































Scheme 1 Enzymatic routes for the synthesis of enantiopure (R)‑2‑hydroxy acids
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strains [35]. Pseudomonas aeruginosa CCTCC M 2011394 
harboring a flavine mononucleotice (FMN)-dependent 
(S)-2-HADH, which specifically oxidizes the (S)-isomer 
of 2-hydroxy acids to 2-keto acids [36], was isolated 
from the soil samples. Thus, (S)-2-HADH may be used 
as the biocatalyst for the oxidation step in the designed 
enantioselective cascade biocatalysis. The gene of (S)-
2-HADH from P. aeruginosa CCTCC M 2011394 (Gen-
Bank accession number: KU612124) was cloned and 
expressed in E. coli BL21(DE3). The recombinant E. coli 
was cultured in LB medium at 37 °C to reach an OD600 of 
0.6 and then induced by the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 0.1  mM. The cells were 
continually grown at 28 °C, 150 rpm for 12 h. The resting 
cells of the recombinant E. coli strain (E. coli BL21(DE3)/
pET28b-HADH) were used as biocatalysts for the enan-
tioselective oxidation of racemic 2-hydroxy acids with 
rac-1a as model substrate. The result showed that the 
activity was lower than 5.0 U/g dry cell weight (DCW) 
and conversion of 2-keto acid 2a was only 5.1 % after 2 h 
reaction (Table 1, entry 1). To achieve economic feasibil-
ity and competitiveness for the enantioselective oxidation 
of 2-hydroxy acids, it is necessary to find an promising 
(S)-2-HADH showing high activity and enantioselectiv-
ity (E). We adopted a genome mining strategy to search 
for more efficient (S)-2-HADHs. A pBLAST search was 
conducted by using (S)-2-HADH from P. aeruginosa 
CCTCCM 2011394 as the template in the NCBI database. 
Four representative (S)-2-HADHs from Burkholderia 
xenovorans LB400 (ABE35802.1), P. putida ATCC 12633 
(AAC15503.1), P. aeruginosa NUST (AGM49308.1), P. 
fluorescens strain EBC191(AAW79575.1) were selected 
(Additional file  1: Figure S1). After being synthesized 
in  vitro and cloned into pET28b, the four (S)-2-HADH 
genes were then expressed in E. coli BL21(DE3), respec-
tively. Rac-1a was used as the model substrate to evaluate 
their activity and enantioselectivity. The results indicated 
that they all displayed oxidation activities. The resting 
cells of recombinant E. coli BL21(DE3) expressing the (S)-
2-HADH from the B. xenovorans LB400 and P. aeruginosa 
NUST showed relatively higher activity (>90 U/g DCW) 
with excellent enantioselectivity (E  >  200). After 2  h 
reaction, the conversions of keto acid 2a reach 49.0 and 
48.9 %, respectively, which were near theoretical conver-
sions. However, sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis showed that (S)-
2-HADH from B. xenovorans LB400 has been expressed 
in partially soluble state. In the forthcoming experiments, 
the (S)-2-HADH from P. aeruginosa NSUT was selected 
for further studies. The requirement of coenzyme in the 
stereoselective oxidation catalyzed by (S)-2-HADH from 
P. aeruginosa NSUT was investigated. The activity of 
(S)-2-HADH was almost lost upon flavin removal. The 
activity of the apoenzyme was partly reactivated by the 
addition of FMN. These results confirmed that the (S)-2-
HADH from P. aeruginosa NUST is a flavoprotein with 
FMN as cofactor. The reaction that oxidizes (S)-2-hydroxy 
acids to 2-keto acids consists of the steps involved in sub-
strate oxidation and FMN reduction [37]. The FMN is 
then reoxidized by electron transfer to the oxidant. The 
FMN-dependent (S)-2-HADH family can be divided 
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Scheme 2 Enantioselective cascade biocatalysis for deracemization of 2‑hydroxy acids to enantiopure 2‑hydroxy acids via an oxidation–reduction 
sequence
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including oxygen, flavocytochrome b2s and ubiquinone 
utilized in the second oxidative half-reaction [37, 38]. 
Operation parameters, including optimum temperature 
and pH of the dehydrogenation by the recombinant E. 
coli BL21(DE3)/pET28b-HADH were investigated. The 
result showed that the resting cells of recombinant E. 
coli BL21(DE3)/pET28b-HADH showed high activity at 
35–55  °C and pH 7.5–8.5 (Additional file  1: Figure S2). 
The wide ranges of optimum temperature and pH are very 
beneficial for the cascade biocatalysis.
Construction of recombinant E. coli strain coexpressing 
(R)‑2‑KAR and GDH
Stereoselective (R)-2-KAR could reduce prochiral 2-keto 
acids to produce corresponding chiral 2-hydroxy acids. 
The gene of (R)-2-KAR cloned from Leuconostoc mesen-
teroides CCTCC M 2016063 (GenBank accession num-
ber: KU612125) was expressed in E. coli BL21(DE3). 
After cultivation, the whole cells of recombinant E. coli 
BL21(DE3)/pET28b-KAR were collected and disrupted 
by sonication. The (R)-2-KAR with N-terminal his-
tag in the cell free extract was purified to homogeneity 
by nickel affinity chromatography. The purified (R)-2-
KAR migrated as a single band and located at the posi-
tion of about 32  kDa on SDS-PAGE (Additional file  1: 
Figure S3), which is in agreement with the molecular 
mass deduced from its amino acid sequence. The puri-
fied enzyme showed little activity with NADPH but full 
activity with NADH, indicating an NADH-dependence. 
For the application of reductase, the addition of expen-
sive cofactor often makes the bioreaction less practi-
cally feasible from the viewpoint of economic aspects. 
A coexpression of two enzymes in one E. coli cell seems 
to be an efficient approach to solve this problem. Thus, 
we introduced a GDH from Exiguobacterium sibiricum 
(WP_012369122.1) for the regeneration of the oxidized 
cofactor (NAD+). A coexpression plasmid (pCDFDuet-
KAR-GDH) containing both (R)-2-KAR and GDH genes 
was constructed and transformed into E. coli BL21(DE3) 
cells. After cultivation, the whole cells of recombinant 
E. coli BL21(DE3)/pCDFDuet-KAR-GDH were col-
lected and disrupted by sonication. The SDS-PAGE of 
the cell free extract of the recombinant E. coli showed 
that the coexpressed (R)-2-KAR and GDH were clearly 
visible (Additional file 1: Figure S4). The (R)-2-KAR and 
GDH located at the position of about 32 and 28 kDa on 
SDS-PAGE. The effects of temperature and pH on the 
reduction by the recombinant E. coli BL21(DE3)/pCDF-
Duet-KAR-GDH were also investigated. The resting cells 
of the recombinant E. coli exhibit high activity at 35  °C 
and pH 7.5 using keto acid 2a as substrate. To test the 
potential of recombinant E. coli BL21(DE3)/pCDFDuet-
KAR-GDH in chemical synthesis, various substrates were 
used for asymmetric reduction. With the assistance of 
GDH from E. sibiricum for cofactor regeneration, the 
resting cells of E. coli strain coexpressing (R)-2-KAR and 
GDH could reduce a wide range of prochiral 2-keto acids 
to corresponding (R)-2-hydroxy acids with >99  % ee. 
The substituents in substrates and the distance between 
the hydroxy group and benzene ring are the important 
factors to affect the catalytic ability of the biocatalyst. 
Among all the 2-hydroxy acids tested, substrate 2a–2m 
could be efficiently reduced to (R)-2-1a–1m in  >86  % 
conversion and >99 % ee within 3.5–10 h (Table 2, entries 
1–13). When the OH and OCH3 were attached to the 
phenyl ring of the substrates (2n–2q) and the distance 
between the hydroxy group and benzene ring increased 
(2r and 2s), the recombinant E. coli exhibited a relatively 
low activity (Table 2, entries 14–19).
Deracemization of 2‑hydroxy acids with the mixtures 
of recombinant E. coli BL21(DE3)/pET28b‑HADH and E. coli 
BL21(DE3)/pCDFDuet‑KAR‑GDH
For developing a process for deracemization of race-
mic 2-hydroxy acids, we coupled the asymmetric oxi-
dation with the opposite stereoselective reduction. 
Table 1 Catalytic performance of resting cells of recombinant E. coli expressing the (S)-2-HADH from different microor-
ganisms
N.D. not determined
a The enzyme assays were performed at 35 °C, pH 7.5 for 10 min. One unit of enzyme activity was defined as the amount of enzyme catalyzing the oxidation of 
substrate 1a for producing 1.0 µmol of keto acid in 1.0 min under standard assay conditions. The substrate concentration was 20 mM
b The conversion of 2-keto acid was calculated when the reactions were carried out for 2 h





1 P. aeruginosa CCTCC M 2011394 <5 5.1 >200
2 P. aeruginosa strain NUST 107.4 48.9 >200
3 B. xenovorans LB400 90.2 49.0 >200
4 P. fluorescens strain EBC191 <5 5.2 N.D.
5 P. putida ATCC 12633 15.0 23.0 N.D.
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Recombinant E. coli BL21(DE3)/pET28b-HADH and 
E. coli BL21(DE3)/pCDFDuet-KAR-GDH were culti-
vated, separately, to achieve the resting cells. The cells 
of the mixed two strains were designed as the catalytic 
system. The enantioselective cascade biocatalysis for 
deracemization of 1a–1s was carried out by a one-pot 
strategy. The conversion, ee of products and reaction 
time were detected (Table  3). The result showed that 
the (R)-isomers of substrates (1a–1m) were obtained 
in high conversions (>90  %) with  >99  % ee. In the case 
of 1n–1s (Table  3, entries 14–19), (R)-2-hydroxy acids 
were obtained with relative low conversion (34.6–76.4 %) 
within 6  h. For the 1p–1q (Table  3, entry 16–17), (R)-
2-hydroxy acids were obtained with high enantiomeric 
excess (>99  %), which indicated that the (S)-isomer of 
2-hydroxy acids were completely oxidized. The lower 
conversion might be due to the accumulation of 2-keto 
acids. Figure  1 shows a typical deracemization progress 
for the preparation of (R)-1a from 1a with the mixtures 
of recombinant E. coli BL21(DE3)/pET28b-HADH and 
Table 2 Reduction of keto acids to corresponding (R)-2-hy-
droxy acids by resting cells of E. coli BL21(DE3)/pCDFDuet-
KAR-GDH
The reactions were performed at 35 °C in phosphate buffer (100 mM, pH 7.5) 
with 4 g DCW/L resting cells of E. coli BL21(DE3)/pCDFDuet-KAR-GDH and 
20 mM substrate






1 2a 3.5 95.4 >99
2 2b 5 97.0 >99
3 2c 6 92.8 >99
4 2d 7 89.3 >99
5 2e 6 90.2 >99
6 2f 6 99.0 >99
7 2g 8 90.0 >99
8 2h 10 87.4 >99
9 2i 9 96.4 >99
10 2j 7 91.5 >99
11 2k 7 86.9 >99
12 2l 8 87.2 >99
13 2m 7 88.5 >99
14 2n 12 26.8 >99
15 2o 12 22.6 >99
16 2p 9 76.4 >99
17 2q 11 25.5 >99
18 2r 12 21.5 >99
19 2s 13 14.0 >99
Table 3 Deracemization of  2-hydroxy acids with  the 
mixtures of  E. coli BL21(DE3)/pET28b-HADH and  E. coli 
BL21(DE3)/pCDFDuet-KAR-GDH
Reactions were performed in one pot at 35 °C in phosphate buffer (100 mM, pH 
7.5) with 4 g DCW/L resting cells of E. coli BL21 (DE3)/pET28b-HADH, 8 g DCW/L 
resting cells of E. coli BL21 (DE3)/pCDFDuet-KAR-GDH and 20 mM substrate






1 rac‑1a 4 94.9 >99
2 rac‑1b 6 94.5 >99
3 rac‑1c 6 93.2 >99
4 rac‑1d 4 95.1 >99
5 rac‑1e 4 96.4 >99
6 rac‑1f 4 97.3 >99
7 rac‑1g 4 97.6 >99
8 rac‑1h 2 95.5 >99
9 rac‑1i 4 96.8 >99
10 rac‑1j 2 94.5 >99
11 rac‑1k 4 96.3 >99
12 rac‑1l 2 96.4 >99
13 rac‑1m 4 94.8 >99
14 rac‑1n 6 35.5 81.9
15 rac‑1o 6 34.6 71.8
16 rac‑1p 6 59.5 >99
17 rac‑1q 6 42.7 >99
18 rac‑1r 6 76.4 63.3
19 rac‑1s 6 58.3 60.1
Fig. 1 Time course of deracemization of rac‑1a with the mixtures 
of recombinant E. coli strain. The freshly prepared cells of E. coli 
BL21(DE3)/pET28b‑HADH and E. coli BL21(DE3)/pCDFDuet‑KAR‑GDH 
were mixed in 10 mL of phosphate buffer (100 mM, pH 7.5) to a cell 
density of 4 and 8 g DCW/L, respectively
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E. coli BL21(DE3)/pCDFDuet-KAR-GDH. Oxidation 
was the faster step in the overall reaction because 2a was 
accumulated in the cascade reaction. After 150 min reac-
tion, the conversion to (R)-1a from racemate was 97 %.
Construction of recombinant E. coli coexpressing 
(S)‑2‑HADH, (R)‑2‑KAR and GDH for deracemization 
of 2‑hydroxy acids by cascade biocatalysis
In order to avoid the respective cultivation of the two 
recombinant strains and reduce the cell concentration 
in the cascade biocatalysis, we attempted to use a single 
recombinant strain coexpressing (S)-2-HADH, (R)-2-
KAR and GDH for the cascade biocatalysis. The recom-
binant E. coli strain expressing all the necessary enzymes 
was constructed. The pET28b-HADH and pCDFDuet-
KAR-GDH with different antibiotic selection were intro-
duced to E. coli BL21(DE3). The recombinant strain was 
selected with LB agar plates containing streptomycin and 
kanamycin. A three-enzyme coexpression strain E. coli 
BL21(DE3)/pET28b-HADH/pCDFDuet-KAR-GDH was 
screened. The SDS-PAGE of the cell free extract of the 
recombinant E. coli showed that the coexpressed (S)-2-
HADH, (R)-2-KAR and GDH were clearly visible (Addi-
tional file  1: Figure S5). The constructed three-enzyme 
system was used for one-pot cascade biocatalysis. The 
recombinant E. coli BL21(DE3)/pET28b-HADH/pCD-
FDuet-KAR-GDH was cultured to achieve the resting 
cells. The cascade oxidation–reduction reaction cata-
lyzed by the resting cells of the recombinant E. coli were 
performed at 35  °C and pH 7.5 (Table  4). The results 
showed that most of those substrates (1a–1m) can be 
obtained in up to 98.5  % conversion and  >99  % ee in a 
shorter reaction time as compared to the mixtures of two 
recombinant E. coli. The reason for this may be that the 
multienzyme in one recombinant strain avoid the trans-
fer of substrates in different cells. Figure 2 shows a typi-
cal time course for production of (R)-1a from racemic 1a 
with a single recombinant E. coli BL21(DE3)/pET28b-
HADH/pCDFDuet-KAR-GDH expressing all the neces-
sary enzymes. After 100 min reaction, (S)-1a was almost 
completely converted to (R)-1a. The results confirmed 
that the three-enzyme coexpressing system was more 
efficient.
Conclusions
In summary, a cascade biocatalysis was successfully devel-
oped to prepare valuable (R)-2-hydroxy acids with an 
efficient three-enzyme system, which was constructed 
by coexpressing (S)-2-HADH, (R)-2-KAR and GDH. The 
recombinant E. coli strain coexpressing the three enzymes 
was proven to be a promising biocatalyst for the cascade 
bioconversion of a structurally diverse range of racemic 
2-hydroxy acids, giving the corresponding (R)-2-hydroxy 
acids in up to 98.5 % conversion and >99 % ee. The devel-
oped elegant cascade biocatalysis possesses high atom 
efficiency and represents a promising strategy for produc-
tion of highly valued (R)-2-hydroxy acids.
Table 4 Deracemization of  2-hydroxy acids with  recombi-
nant E. coli coexpressing (S)-2-HADH, (R)-2-KAR and GDH
Reactions were performed in one pot at 35 °C in phosphate buffer (100 mM, pH 
7.5) with 8 g DCW/L resting cells of E. coli BL21(DE3)/pET28b-HADH/pCDFDuet-
KAR-GDH and 20 mM substrate






1 rac‑1a 2 95.2 >99
2 rac‑1b 2 92.7 >99
3 rac‑1c 2 95.8 >99
4 rac‑1d 4 95.9 >99
5 rac‑1e 2 98.5 >99
6 rac‑1f 2 98.2 >99
7 rac‑1g 2 97.4 >99
8 rac‑1h 2 97.7 >99
9 rac‑1i 2 96.6 >99
10 rac‑1j 2 97.1 >99
11 rac‑1k 2 97.4 >99
12 rac‑1l 2 96.9 >99
13 rac‑1m 2 97.7 >99
14 rac‑1n 6 37.4 91.5
15 rac‑1o 6 33.9 73.6
16 rac‑1p 6 76.9 >99
17 rac‑1q 6 40.5 >99
18 rac‑1r 6 90.7 85.8
19 rac‑1s 6 82.4 78.6
Fig. 2 Time course of deracemization of rac‑1a with a single recom‑
binant E. coli strain. The freshly prepared cells of E. coli BL21(DE3)/
pET28b‑HADH/pCDFDuet‑KAR‑GDH were resuspended in 10 mL 
phosphate buffer (100 mM, pH 7.5) to a cell concentration of 8 g 
DCW/L
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Methods
Materials
1a–1s, (R)-1a, (S)-1a and benzoyl formic acid were pro-
vided from J&K Chemical Co., Ltd. (Shanghai, China). All 
other chemicals used were of analytical grade and com-
mercially available. DNA purification kits, restriction endo-
nucleases, T4 DNA ligase, Pfu DNA polymerase, and Taq 
DNA polymerase were purchased from Shenergy Biocolor 
BioScience and Technology Company (Shanghai, China). 
The pGEM-T (Promega, Madison, WI, USA) was used as 
cloning vector. The pETDuet-1 and pET28b (Novagen, 
Darmstadt, Germany) were used as expression vector.
Construction of recombinant E. coli BL21(DE3)/
pET28b‑HADH
The gene encoding (S)-2-HADH from P. aeruginosa 
CCTCC M 2011394 was amplified via PCR with a series 
of primers (F-1 GGTGAAACACAACCGCGA; R-1 AGG 
GCATCCAATCTGGGC, F-2 CTATGGTTCCAGCTCT 
ATGTG; R-2 AGTTGGCGACCGCCGTG, F-3 CATGC 
CGCAACTGGCCAA; R-3 TGCGGTCGATATCCG 
CTTT). (S)-2-HADH gene was amplified via PCR with 
primers (F- GGAATTCCATATGATGATCATTTCCG 
CTTCCACC, R- CCCAAGCTTTCAGGCGCCCAGT 
TCGCGGACCA) designed according to the sequence 
similarity. The PCR product was digested with NdeI 
and HindIII and ligated into pET28b. The recombinant 
plasmids were transformed into E. coli BL21(DE3) for 
expression. A pBLAST search was conducted by using 
(S)-2-HADH from P. aeruginosa CCTCCM 2011394 as 
the template in the NCBI database. The (S)-2-HADH 
from B. xenovorans LB400 (ABE35802.1), P. putida 
(AAC15503.1), P. aeruginosa NUST (AGM49308.1), P. 
fluorescens strain EBC191 (AAW79575.1) were selected. 
Nucleotide sequences of (S)-2-HADHs from these strains 
were synthesized using the polymerase chain reaction 
assembly method [39]. The coding genes were ligated 
into pET28b and expressed in E. coli BL21(DE3). For the 
selection of E. coli BL21(DE3) transformants, 50  μg/mL 
kanamycin was added to the Luria–Bertani (LB) medium 
(5 g yeast extract, 10 g tryptone, and 10 g NaCl in 1 L of 
distilled water). The requirement of coenzyme in the ste-
reoselective oxidation catalyzed by (S)-2-HADH from 
P. aeruginosa NSUT was investigated according to the 
method as described previously [40].
Construction of recombinant E. coli BL21(DE3)/
pCDFDuet‑KAR‑GDH
The gene of (R)-2-KAR from L. mesenteroides CCTCC M 
2016063 was amplified via PCR with primers (F-AGGCC 
ATGGGTAAAATCGCAATTGCCG, R-AATCTCG 
AGGATCTCGAAGTTCTCTTGC). The gene of GDH 
from E. sibiricum (WP_012369122.1) was synthesized 
in vitro. The genes of (R)-2-KAR and GDH were cloned 
and inserted into the coexpression vector pCDFDuet. 
The pCDFDuet-KAR-GDH was transformed into E. coli 
BL21(DE3) for expression. For the selection of E. coli 
BL21(DE3) transformants (E. coli BL21(DE3)/pCDF-
Duet-KAR-GDH), 50 μg/mL streptomycin was added to 
the LB medium.
Construction of recombinant E. coli BL21(DE3)/
pET28b‑HADH/pCDFDuet‑KAR‑GDH
pET28b-HADH and pCDFDuet-KAR-GDH with dif-
ferent antibiotic selection were transformed into E. coli 
BL21(DE3). The recombinant strain (E. coli BL21(DE3)/
pET28b-HADH/pCDFDuet-KAR-GDH) was selected 
with LB agar plates containing 50  μg/mL streptomycin 
and 50 μg/mL kanamycin.
Microorganisms and culture conditions
P. aeruginosa CCTCCM 2011394 was cultured at 30 °C in 
rich medium containing 10 g glucose, 10 g yeast extract, 
2.5 g K2HPO4·3H2O, 2.5 g KH2PO4, 0.2 g MgSO4·7 H2O, 
0.03  g FeSO4·7 H2O and 1.0  g NaCl in 1  L of distilled 
water (pH 7.0). L. mesenteroides CCTCC M 2016063 was 
cultured at 30  °C in complete medium containing 10  g 
glucose, 10  g yeast extract, 10  g tryptone, 5  g NaCl and 
5 g beef extract in 1 L of distilled water (pH 7.0). E. coli 
BL21(DE3) (Novagen, Darmstadt, Germany) were used 
for gene expression. The E. coli strains were grown at 
37 °C in LB medium. The recombinant E. coli strains were 
grown at 37  °C in LB medium containing appropriate 
antibiotics (50 μg/mL streptomycin, or 50 μg/mL kanamy-
cin, or both) to reach an OD600 of 0.6 and then induced by 
adding IPTG at 0.1 mM. The strains were cultured contin-
ually at 28 °C, 150 rpm for 12 h. The whole cells were col-
lected by centrifugation at 9000×g under 4 °C for 10 min, 
washed twice with 100 mM phosphate buffer (pH 7.5) for 
activity test and biotransformation.
Cascade deracemization of 2‑hydroxy acids with mixture 
of the resting cells of recombinant E. coli BL21(DE3)/
pET28b‑HADH and E. coli BL21(DE3)/pCDFDuet‑KAR‑GDH
The freshly prepared whole cells of E. coli BL21(DE3)/
pET28b-HADH and E. coli BL21(DE3)/pCDFDuet-KAR-
GDH were suspended in 10  mL of phosphate buffer 
(100  mM, pH 7.5) to a cell concentration of 4 and 8  g 
DCW/L, respectively. Racemic 2-hydroxy acids 1a–1s 
was added to the mixture at a final concentration of 
20 mM. The mixtures were shaken at 35 °C and 150 rpm 
in 50-mL flasks. Samples were taken at regular intervals 
and the reactions were terminated through centrifuga-
tion (12,000×g, 4  °C, 5  min). The conversion and ee of 
products were determined by chiral high-performance 
liquid chromatographic (HPLC) method.
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Cascade deracemization of 2‑hydroxy acids with the 
resting cells of recombinant E. coli BL21(DE3)/
pET28b‑HADH/pCDFDuet‑KAR‑GDH
The freshly prepared cells of E. coli BL21(DE3)/pET28b-
HADH/pCDFDuet-KAR-GDH were resuspended to a 
cell concentration of 8  g DCW/L in 10  mL phosphate 
buffer (100 mM, pH 7.5) containing 20 mM 1a–1s. The 
mixtures were shaken at 35  °C and 150  rpm in 50-mL 
flasks. Samples were taken at regular intervals and 
the reactions were terminated through centrifugation 
(12,000×g, 4  °C, 5  min). The conversion and ee values 
were determined by chiral HPLC method.
Analytical methods
The determination of (R)-1a–1s, (S)-1a–1s and 2a–2s 
was performed by chiral HPLC equipped with a chiral 
column (ChirobioticTM R 250  ×  4.6  mm, particle size 
5  μm, Sigma, USA). The flow rate was set at 1.0  mL/
min. The mobile phase was composed of 0.5 % NH4OH-
CH3OH (10:90, v/v). The eluate was monitored at 
215 nm. Enantioselectivity (E) was calculated from con-
version and ee as described previously [41].
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Additional file 1: Figure S1. Amino acid sequences multiple alignment 
of 2‑HADH from P. aeruginosa CCTCC M 2011394, B. xenovorans LB400, P. 
putida ATCC 12633, P. aeruginosa NUST, P. fluorescens strain EBC191. Figure 
S2. Optimization of biooxidation reaction conditions by resting cells of 
recombinant E. coli BL21(DE3)/pET28b‑HADH. (A) Effect of temperature 
on the biooxidation. The optimum temperature was determined over 
the range from 25 and 65 °C. The recombinant E. coli BL21(DE3)/pET28b‑
HADH showed high activity at 35–55 °C, and at higher temperatures the 
activity began to decrease significantly. (B) Effect of pH on the biooxida‑
tion; The optimum pH on the oxidation reaction was determined over 
the range from 6.0 and 9.0. When the pH was below 7.5 or over 8.5, the 
enzyme activity decreased dramatically. Figure S3. SDS‑PAGE analysis of 
the expressed (R)‑2‑KAR in recombinant E. coli BL21(DE3)/pET28b‑KAR. 
1. Markers; 2. Cell‑free extract of recombinant E. coli BL21(DE3)/pET28b‑
KAR; 3. Purified (R)‑2‑KAR from E. coli BL21(DE3)/pET28b‑KAR (~32 kDa). 
Figure S4. SDS‑PAGE analysis of the expressed GDH in recombinant 
E. coli BL21(DE3)/pET28b‑GDH and coexpressed (R)‑2‑KAR and GDH in 
recombinant E. coli BL21(DE3)/pCDFDuet‑KAR‑GDH. 1. E. coli BL21(DE3)/
pCDFDuet‑KAR‑GDH with 0.1 mM IPTG. The upper arrow indicated (R)‑
2‑KAR (~32 kDa) and the lower arrow represented GDH (~28 kDa).2. E. 
coli BL21(DE3)/pCDFDuet‑KAR‑GDH with 0 mM IPTG; 3. E. coli BL21(DE3)/
pET28b‑GDH with 0.1 mM IPTG; 4. E. coli BL21(DE3)/pET28b‑GDH with 
0 mM IPTG; 5.Empty plasmid of pET28b with 0 mM IPTG. 6. Markers. 
Figure S5. SDS‑PAGE analysis of the coexpressed (S)‑2‑HADH, (R)‑2‑KAR 
and GDH in recombinant E. coli BL21(DE3)/pET28b‑HADH/pCDFDuet‑
KAR‑GDH. 1. Markers; 2. Cell‑free extract of recombinant E. coli BL21(DE3)/
pET28b‑HADH/pCDFDuet‑KAR‑GDH. The upper arrow indicated (S)‑2‑
HADH (~42 kDa), the middle arrow indicated (R)‑2‑KAR (~32 kDa) and the 
lower arrow represented GDH (~28 kDa).
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